Answer
Asciminib hydrochloride (Scemblix) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1 of its product information.
Sources for this answer
- Scemblix 20 mg and 40 mg film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 9Document updated
Sources checked